PBF-999 is a phosphodiesterase10A (PDE-10A) and adenosine A2A receptor (A2AR) dual antagonist. PBF-999 binds to and inhibits the activity of PDE-10A, thereby preventing the degradation of cGMP. PBF-999 can be used for the study of solid tumour advanced cancer [1].
References:
[1]. Yu F, et al. Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. J Med Chem. 2020 Nov 12;63(21):12196-12212.
References:
[1]. Yu F, et al. Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. J Med Chem. 2020 Nov 12;63(21):12196-12212.
















